Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

One‐Pot Microwave‐Assisted Synthesis, in Vitro Anti‐inflammatory Evaluation and Computer‐Aided Molecular Design of Novel Sulfamide‐Containing Bisphosphonates Derivatives

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Université Badji Mokhtar Annaba (UBMA); Centre de Recherche en Biotechnologie (CRBt); Unité de Recherche de Chimie de l'Environnement et Moléculaire Structurale (CHEMS); Université Frères Mentouri – Constantine 1 = Constantine 1 – Frères Mentouri University (UMC); PEIRENE (PEIRENE); Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST); Université de Limoges (UNILIM)-Université de Limoges (UNILIM); Institut des Sciences Moléculaires de Marseille (ISM2); Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)
    • Publication Information:
      HAL CCSD
      Wiley
    • Publication Date:
      2022
    • Collection:
      Université de Limoges: HAL
    • Abstract:
      International audience ; An eco-friendly and one-step microwave-assisted green synthesis of new functionalized bisphosphonates derivatives was described by a three-component reaction of aromatic sulfamide with triethyl orthoformate and diethyl phosphite. The synthesized compounds were characterized by 1 H, 13 C, 31 P NMR and IR analysis. Some of these compounds were tested for in vitro anti-inflammatory activity and showed moderate inhibition compared to diclofenac as standard drug. Furthermore, to rationalize the observed biological data, several in silico approaches have been used to explain Structure-Activity Relationship study (SAR) based on DFT calculation, molecular docking, pharmacodynamic, pharmacokinetic and toxicity profiles of sulfamide-containing bisphosphonates derivatives as anti-inflammatory drugs. The results of the in vitro and in silico activities prove that the compound 4 b have the ideal structural requirements for further development of novel anti-inflammatory agents.
    • Relation:
      hal-03959428; https://hal.science/hal-03959428; https://hal.science/hal-03959428/document; https://hal.science/hal-03959428/file/2022-4.pdf
    • Accession Number:
      10.1002/slct.202201889
    • Online Access:
      https://hal.science/hal-03959428
      https://hal.science/hal-03959428/document
      https://hal.science/hal-03959428/file/2022-4.pdf
      https://doi.org/10.1002/slct.202201889
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.C4E6C1D3